Skip to main content
Photocure ASA logo

Photocure ASA — Investor Relations & Filings

Ticker · PHO ISIN · NO0010000045 LEI · 5967007LIEEXZXG8OW35 OL Manufacturing
Open in API
Filings indexed 1,331 across all filing types
Latest filing 2019-10-30 Report Publication Anno…
Country NO Norway
Listing OL PHO

About Photocure ASA

https://www.photocure.com/

Photocure is a specialty pharmaceutical company focused on bladder cancer. It develops and commercializes products and medical devices based on proprietary photodynamic technology. The company's primary offering is Blue Light Cystoscopy (BLC) with its imaging agents, Hexvix®/Cysview®, which is used for the improved detection and management of bladder cancer. Photocure aims to deliver transformative solutions to the urologic oncology community to improve patient outcomes. The company is also engaged in developing advanced diagnostic technologies, including the integration of artificial intelligence with its BLC systems.

Recent filings

Filing Released Lang Actions
Photocure ASA: Invitation to third quarter 2019 results presentation and webcast
Report Publication Announcement Classification · 98% confidence The document is an invitation detailing the time, date, and location for the presentation of the 'third quarter 2019 report'. It explicitly states that the quarterly report and presentation will be published at 07:00 CET and provides webcast details. Since the document itself is an announcement about the upcoming release and presentation of results, rather than the full results (ER) or the comprehensive quarterly report (IR), it fits best as a Report Publication Announcement (RPA). The length (1159 chars) strongly supports this, as it is an invitation/notice, not the full financial document.
2019-10-30 English
Photocure: New data from Hexvix® trials presented at the BLADDR 2019 congress
Regulatory Filings Classification · 95% confidence The document is a press release dated October 28th, 2019, announcing that new data regarding the company's product, Hexvix®, was presented at the BLADDR 2019 congress. It details the findings from two studies and includes quotes from the CEO. This format—a brief announcement highlighting recent corporate or scientific news, often released outside of mandatory SEC filing cycles—is characteristic of a general press release or regulatory announcement. Since it is not a full financial report (10-K, IR), a specific management change (MANG), or a formal voting result (DVA), and it serves to disseminate timely corporate information, it best fits the general 'Regulatory Filings' (RNS) category, which acts as a catch-all for significant, non-standard announcements, or potentially an Earnings Release (ER) if it were tied to a specific reporting period, but here it is focused on clinical data presentation. Given the content is a scientific/corporate update rather than a financial result summary, RNS is the most appropriate fit as a general regulatory disclosure.
2019-10-28 English
Photocure to present at Norne Securities Vekst & Verdi Aksjeseminar in Vilnius
Regulatory Filings Classification · 95% confidence The document is a very short announcement (1114 characters) stating that Photocure management will be presenting at the 'Norne Securities Vekst & Verdi Aksjeseminar' on September 20, 2019. It explicitly mentions that the presentation will be posted on their website when held. This structure—announcing participation in an event where a presentation will be given or made available—fits the definition of a Report Publication Announcement (RPA) or, more generally, a Regulatory Filing (RNS) if the presentation itself is not the primary focus. Since the document is an announcement about a future presentation/material release rather than the material itself, and it is not a standard regulatory form (like 10-K or ER), RPA is the most appropriate classification based on the 'MENU VS MEAL' rule, as it announces the publication of presentation materials.
2019-09-19 English
Photocure to present at the H.C. Wainwright 21st Annual Healthcare Conference in New York
Report Publication Announcement Classification · 85% confidence The document is a short press release announcing that Photocure's management will be presenting at the 'H.C. Wainwright 21st Annual Healthcare Conference' on a specific date. It mentions that the presentation will be posted online when held. This is not the presentation itself, nor is it a formal regulatory filing like a 10-K or ER. It is an announcement about an upcoming investor event/presentation. Since there is no specific category for 'Investor Event Announcement' and the content relates to investor relations activities, the closest fit among the provided options is 'Investor Presentation' (IP) if we assume the announcement is directly preceding or related to the distribution of the presentation materials, or 'Regulatory Filings' (RNS) as a general announcement. Given the context of presenting at a conference, 'Investor Presentation' (IP) is the most contextually relevant classification, even though the text itself is just the announcement of the event, not the presentation slides. However, following the 'MENU VS MEAL' rule strictly, this is an announcement about a future presentation, not the presentation itself. If the document were the actual presentation slides, it would be IP. Since it is an announcement about an event where a presentation will occur, and it is short, it could be RNS. Let's re-evaluate the definitions. None perfectly fit 'Conference Presentation Announcement'. Given that the announcement explicitly states the presentation will be posted online when held, it functions as a notice regarding investor engagement. 'Investor Presentation' (IP) is the most specific category related to the subject matter (a presentation at a healthcare conference). I will classify it as IP, assuming the intent is to categorize documents related to investor presentations.
2019-09-03 English
Photocure to present at the H.C. Wainwright 21st Annual Healthcare Conference in New York
Report Publication Announcement Classification · 99% confidence The document is a short announcement stating that Photocure ASA management will be presenting at the 'H.C. Wainwright 21st Annual Healthcare Conference' on a specific date. It mentions that the presentation will be posted online when held. This fits the definition of an announcement regarding participation in an investor event, which is best categorized as an Investor Presentation (IP) announcement or, more generally, a Regulatory Filing (RNS) if a specific investor event announcement code isn't available. However, since the content is about an upcoming presentation to investors, and it is very short (1132 chars), it strongly suggests an announcement rather than the presentation itself. Given the options, 'Investor Presentation (IP)' is the most relevant theme, but since this is an announcement *about* presenting, and not the presentation material itself, and there is no specific code for 'Investor Event Announcement', I must check if it fits 'RPA' (Report Publication Announcement). It is not announcing the publication of a formal financial report (like 10-K or IR). Therefore, the most appropriate general category for an announcement about investor engagement is 'Regulatory Filings' (RNS) as a catch-all for non-standard announcements, or if we interpret 'IP' as covering all investor-related news, we might lean towards that. Given the context of investor conferences, this is often grouped with investor relations material. Since it is an announcement about an upcoming presentation, and not the presentation itself, RNS is the safest fallback, but IP is thematically closest. Let's re-evaluate the definitions. None explicitly cover 'Investor Conference Presentation Announcement'. Since it is a brief announcement about an event where an investor presentation will occur, and it is not a formal report, RNS is the most appropriate fallback for miscellaneous regulatory/corporate news.
2019-09-03 English
Photocure ASA: Results for the second quarter and first half of 2019
Earnings Release Classification · 99% confidence The document explicitly states it is the 'Second quarter report 2019 Q2' and contains detailed financial tables (revenues, EBITDA, expenses) and operational highlights for the second quarter and year-to-date period. This structure and content clearly identify it as a comprehensive financial report covering a period shorter than a full year. This matches the definition of an Interim / Quarterly Report (IR). It is not an Earnings Release (ER) because it is a comprehensive report, not just the initial highlights, and it is not a 10-K as it covers only Q2. Q2 2019
2019-08-07 English

Browse filings by year

15 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.